Skip to content

TAXAPHARM: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

TAXAPHARM

BE 0879.817.912
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€64,664
2024 · -€13,121-€51,543
Equity
-€446,038
2024 · -€381,374-€64,664
Cash
€1,448
2024 · €7,184-€5,736
Balance sheet total
€35,480
2024 · €126,293-€90,813

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€53,210

    no longer reported in 2025 (was €53,210)

  • Receivables within one year -€25,649

    down €25,649 (-76.5%), from €33,542 to €7,893

    of which Trade receivables: -€25,668

  • Cash -€5,736

    down €5,736 (-79.8%), from €7,184 to €1,448

    mainly Net result for the year (-€64,664) and Trade debts (-€37,005)

  • Tangible fixed assets -€5,142

    down €5,142 (-16.4%), from €31,281 to €26,139

    of which Plant, machinery and equipment: -€3,913

Equity and liabilities
  • Profit (loss) carried forward -€64,664

    down €64,664 (-16.1%), from -€401,834 to -€466,498

  • Trade debts -€37,005

    down €37,005 (-25.1%), from €147,654 to €110,648

  • Other debts +€13,390

    up €13,390 (+5.4%), from €247,966 to €261,356

  • Tax, wage and social debts -€5,150

    down €5,150 (-62.6%), from €8,234 to €3,083

  • Short-term financial debts +€2,616

    up €2,616 (+11.3%), from €23,190 to €25,806

Income statement
  • Gross operating margin -€112,098

    down €112,098, from €76,170 to -€35,928

  • Staff costs -€58,258

    down €58,258 (-78.9%), from €73,860 to €15,602

  • Financial charges -€2,464

    down €2,464 (-34.0%), from €7,246 to €4,782

  • Other operating charges +€1,597

    up €1,597 (+96.9%), from €1,647 to €3,243

  • Depreciation -€1,439

    down €1,439 (-21.9%), from €6,581 to €5,142

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€13,121
Gross operating margin -€112,098
Staff costs +€58,258
Depreciation +€1,439
Other operating charges -€1,597
Financial income -€10
Financial charges +€2,464
Result 2025 -€64,664
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€8,352
Investment €0
Financing +€2,616
Cash 2024 €7,184
Net result for the year -€64,664
Depreciation +€5,142
Stocks and contracts +€53,210
Receivables within one year +€25,649
Deferred charges and accrued income +€1,076
Trade debts -€37,005
Tax, wage and social debts -€5,150
Other debts +€13,390
Short-term financial debts +€2,616
Cash 2025 €1,448
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €126,293 €35,480 -€90,813 -71.9%
Fixed assets 21/28 €31,281 €26,139 -€5,142 -16.4%
Tangible fixed assets 22/27 €31,281 €26,139 -€5,142 -16.4%
Plant, machinery and equipment 23 €30,052 €26,139 -€3,913 -13.0%
Furniture and vehicles 24 €1,229 - -€1,229
Current assets 29/58 €95,012 €9,341 -€85,671 -90.2%
Stocks and contracts in progress 3 €53,210 - -€53,210
Stocks 30/36 €53,210 - -€53,210
Amounts receivable within one year 40/41 €33,542 €7,893 -€25,649 -76.5%
Trade receivables 40 €27,258 €1,590 -€25,668 -94.2%
Other amounts receivable 41 €6,283 €6,303 +€19 +0.3%
Cash at bank and in hand 54/58 €7,184 €1,448 -€5,736 -79.8%
Deferred charges and accrued income 490/1 €1,076 - -€1,076
Total equity and liabilities 10/49 €126,293 €35,480 -€90,813 -71.9%
Equity 10/15 -€381,374 -€446,038 -€64,664 -17.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 -€401,834 -€466,498 -€64,664 -16.1%
Amounts payable 17/49 €507,668 €481,518 -€26,150 -5.2%
Amounts payable after more than one year 17 €75,000 €75,000 = 0.0%
Financial debts 170/4 €75,000 €75,000 = 0.0%
Amounts payable within one year 42/48 €427,043 €400,893 -€26,150 -6.1%
Financial debts 43 €23,190 €25,806 +€2,616 +11.3%
Credit institutions 430/8 €23,190 €25,806 +€2,616 +11.3%
Trade debts 44 €147,654 €110,648 -€37,005 -25.1%
Suppliers 440/4 €147,654 €110,648 -€37,005 -25.1%
Taxes, remuneration and social security 45 €8,234 €3,083 -€5,150 -62.6%
Remuneration and social security 454/9 €8,234 €3,083 -€5,150 -62.6%
Other amounts payable 47/48 €247,966 €261,356 +€13,390 +5.4%
Accrued charges and deferred income 492/3 €5,625 €5,625 = 0.0%
Non-recurring operating income 76A €1,790 - -€1,790
Remuneration, social security and pensions 62 €73,860 €15,602 -€58,258 -78.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,581 €5,142 -€1,439 -21.9%
Other operating charges 640/8 €1,647 €3,243 +€1,597 +96.9%
Gross operating margin 9900 €76,170 -€35,928 -€112,098
Operating profit (loss) 9901 -€5,917 -€59,914 -€53,997 -913%
Financial income 75/76B €42 €32 -€10 -23.9%
Recurring financial income 75 €42 €32 -€10 -23.9%
Financial charges 65/66B €7,246 €4,782 -€2,464 -34.0%
Recurring financial charges 65 €7,246 €4,782 -€2,464 -34.0%
Profit (loss) for the period before taxes 9903 -€13,121 -€64,664 -€51,543 -393%
Profit (loss) for the period 9904 -€13,121 -€64,664 -€51,543 -393%
Profit (loss) for the period to be appropriated 9905 -€13,121 -€64,664 -€51,543 -393%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.